speb/financial-data huggingface dataset:
DIA.MC balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 58054523.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 80924000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 80924000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Equity Interest: 7571000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 7571000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 29155000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 29155000.00
DIA.MC cash_flow (annual, 2025-12-31) — Other Non Cash Items: 105331000.00
DIA.MC income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 38854000.00
DIA.MC income_statement (annual, 2025-12-31) — Other Operating Expenses: 470234000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Payable: 70281000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Payable: 70281000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Properties: 96677000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Properties: 96677000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Receivables: 8218000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Receivables: 8218000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 497000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 497000.00
DIA.MC income_statement (annual, 2025-12-31) — Other Special Charges: 10022000.00
DIA.MC income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
DIA.MC balance_sheet (annual, 2025-12-31) — Payables: 1066531000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Payables: 1066531000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 48941000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 48941000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 8487000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 8487000.00
DIA.MC income_statement (annual, 2025-12-31) — Pretax Income: 62390000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Properties: 0.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
DIA.MC cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 290000.00
DIA.MC cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -15734000.00
DIA.MC cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5555000.00
DIA.MC cash_flow (annual, 2025-12-31) — Purchase Of PPE: -165147000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Raw Materials: 3437000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Raw Materials: 3437000.00
DIA.MC income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 4215044000.00
DIA.MC income_statement (annual, 2025-12-31) — Reconciled Depreciation: 299493000.00
DIA.MC income_statement (annual, 2025-12-31) — Rent And Landing Fees: 15586000.00
DIA.MC income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 15586000.00
DIA.MC cash_flow (annual, 2025-12-31) — Repayment Of Debt: -32244000.00
DIA.MC cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -117000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Retained Earnings: 128980000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 128980000.00
DIA.MC cash_flow (annual, 2025-12-31) — Sale Of Investment: 9863000.00
DIA.MC cash_flow (annual, 2025-12-31) — Sale Of PPE: 5780000.00
DIA.MC income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 37523000.00
DIA.MC income_statement (annual, 2025-12-31) — Selling General And Administration: 37523000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Share Issued: 58058898.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Share Issued: 58058898.00
DIA.MC income_statement (annual, 2025-12-31) — Special Income Charges: -8872000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 125432000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 125432000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Tangible Book Value: -188859000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -188859000.00
DIA.MC income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -2061750.00
DIA.MC income_statement (annual, 2025-12-31) — Tax Provision: -52122000.00
DIA.MC income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.25
DIA.MC balance_sheet (annual, 2025-12-31) — Taxes Receivable: 20248000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 20248000.00
DIA.MC cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -3260000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Assets: 2310060000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Assets: 2310060000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Capitalization: 642057000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 642057000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Debt: 951932000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Debt: 951932000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 125432000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 125432000.00
DIA.MC income_statement (annual, 2025-12-31) — Total Expenses: 5556873000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 2184628000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2184628000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1526411000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1526411000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 787324000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 787324000.00
DIA.MC income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 149402000.00
DIA.MC income_statement (annual, 2025-12-31) — Total Other Finance Cost: 16730000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Total Tax Payable: 38257000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 38257000.00
DIA.MC income_statement (annual, 2025-12-31) — Total Unusual Items: -8247000.00
DIA.MC income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -8247000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 4375.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 4375.00
DIA.MC balance_sheet (annual, 2025-12-31) — Treasury Stock: 278000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 278000.00
DIA.MC balance_sheet (annual, 2025-12-31) — Working Capital: -613655000.00
DIA.MC balance_sheet (quarterly, 2025-12-31) — Working Capital: -613655000.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -4878095823.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 10311346552.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -6696338681.00
DIACABS.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 26971067.00
DIACABS.NS income_statement (annual, 2022-03-31) — Basic EPS: -9.40
DIACABS.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1854490995.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Cash Financial: -26099910.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 0.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 31399.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Defined Pension Benefit: 15000322.00
DIACABS.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 26971067.00
DIACABS.NS income_statement (annual, 2022-03-31) — Diluted EPS: -9.40
DIACABS.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 165660.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 354118144.00
DIACABS.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 20253203.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 9782584801.00
DIACABS.NS income_statement (annual, 2022-03-31) — Interest Income: 0.00
DIACABS.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 0.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Investmentsin Associatesat Cost: 50322213.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Investmentsin Subsidiariesat Cost: 1288300.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 0.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 8478000.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 1031213939.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 51610513.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 12242641469.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 0.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Assets: 42817781.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 12881582.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 92518924.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 414187657.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Other Investments: 65090000.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: -2.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: -1.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Other Payable: 4230133467.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 150617231.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 8431362.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Preferred Securities Outside Stock Equity: 712274419.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Preferred Shares Number: 4141500.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 3009513104.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -1830000.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 60069513.00
DIACABS.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 0.00
DIACABS.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 0.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 61600561.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -19932581296.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 0.00
DIACABS.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 332288.00
DIACABS.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 20585491.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Short Term Debt Issuance: 8478000.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 18774386.00
DIACABS.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: 0.00
DIACABS.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 69194310.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 17101709.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Tradeand Other Payables Non Current: 145657814.00
DIACABS.NS balance_sheet (annual, 2022-03-31) — Work In Process: 59851975.00
DIACABS.NS income_statement (annual, 2023-03-31) — +Operating Expense: 317713000.00
DIACABS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 139637000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 286637000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 65753000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -5066464000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -9782617000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 11339000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 526971060.00
DIACABS.NS income_statement (annual, 2023-03-31) — Basic EPS: -0.81
DIACABS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 35501000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1854504000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -13754000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 37232000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 37232000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 37232000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -206097000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 2390263000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 60525000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Change In Payable: -757698000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 3171101000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 4652472000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 1011233000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: -9798886000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Common Stock Payments: -2170136000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 1884504000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 246821000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 1454667000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 443000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 443000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 433243000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 8211000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Depreciation: 188369000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 188369000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 188369000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 188369000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 526971060.00
DIACABS.NS income_statement (annual, 2023-03-31) — Diluted EPS: -0.81
DIACABS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -428787000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 0.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 0.00
DIACABS.NS income_statement (annual, 2023-03-31) — EBIT: -422748000.00
DIACABS.NS income_statement (annual, 2023-03-31) — EBITDA: -234379000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 62489000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -3517362000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 254623000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 4404817000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 0.00
DIACABS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 94495000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 9848370000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 17649429000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Gross Profit: -107184000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Interest Expense: 6039000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 6039000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Interest Income: 2462000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 2462000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -6516000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Inventory: 680137000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 13635255000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: 110024000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Investment Properties: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 11339000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 1031214000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 23433698000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 23433698000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 12252891000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: -2170136000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Net Debt: 23396909000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Income: -428787000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -428787000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -428787000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -428787000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -428787000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -428787000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -428787000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Interest Income: -4054000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 116701000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -1432644000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 22519826000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -4054000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Other Financing Charges: 91934000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 208677000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Net PPE: 12582965000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -13754000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -23952470000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: -9798886000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 30522000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: -234379000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Normalized Income: -428787000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 4418571000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Operating Income: -424897000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Operating Revenue: 139637000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 526971060.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Other Cash Adjustment Outside Changein Cash: -984245000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 131200000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: -10325857000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 29966000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 6516000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 13000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: -1000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 167000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 17384000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Payable: 14043000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Properties: 626316000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 356000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: -50691695.00
DIACABS.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Payables: 315561000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 24189000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Preferred Securities Outside Stock Equity: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 645932000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Pretax Income: -428787000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -13754000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 318590000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 246821000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 188369000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 1100666.00
DIACABS.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 1100666.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: -2170136000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 25257000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -20481446000.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
DIACABS.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1460000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 95955000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Share Issued: 526971060.00
DIACABS.NS income_statement (annual, 2023-03-31) — Special Income Charges: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: -9798886000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: -9798886000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
DIACABS.NS income_statement (annual, 2023-03-31) — Tax Provision: 0.00
DIACABS.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 0.00
DIACABS.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Assets: 14068154000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 13634812000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Debt: 23434141000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: -9798886000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Total Expenses: 564534000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 23867040000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 12613487000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 23433797000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 477000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 14881000.00
DIACABS.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 0.00
DIACABS.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 0.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Work In Process: 76958000.00
DIACABS.NS balance_sheet (annual, 2023-03-31) — Working Capital: 1021424000.00
DIACABS.NS income_statement (annual, 2024-03-31) — +Operating Expense: 386459000.00
DIACABS.NS income_statement (annual, 2024-03-31) — +Total Revenue: 3352558000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 1033559000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 587869000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5262094000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 0.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -9782617000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Amortization: 3866000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 9401000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 526971060.00
DIACABS.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.32
DIACABS.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 37232000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1857665000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -163803000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 31102000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 44487000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 44487000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 44487000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -522701000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -64050000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 179358000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Change In Payable: 754033000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -522116000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -173532000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 112062000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: -9733444000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1976969000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 2734405000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Current Assets: 2613669000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 2219000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Current Debt: 598007000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 600226000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1961916000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 8533000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Depreciation: 195627000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 195627000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 195627000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 191761000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 526971060.00
DIACABS.NS income_statement (annual, 2024-03-31) — Diluted EPS: 0.32
DIACABS.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 170250000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 0.00
DIACABS.NS income_statement (annual, 2024-03-31) — EBIT: 236101000.00
DIACABS.NS income_statement (annual, 2024-03-31) — EBITDA: 431728000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — End Cash Position: 44486000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 41941000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 269500000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 98740000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 0.00
DIACABS.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 108453000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 0.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 10370486000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 17813232000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Gross Profit: 618153000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Interest Expense: 67064000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 67064000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Interest Income: 5177000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 5177000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -70198000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Inventory: 1202838000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 13787853000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -192422000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Investment Properties: 0.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 9401000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 1031239000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 28883000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 22923290000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 22952173000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 1621000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 12285763000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Net Debt: 23476810000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Income: 170250000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 170250000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 170250000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 170250000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 170250000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 170250000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 170250000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Interest Income: -61946000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 0.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 81038000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 87699000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -61946000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -1000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -28619000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Net PPE: 12551138000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -163803000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: -6661000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: -9733444000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 1213000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1621000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 10560000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 434753000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Normalized Income: 172367500.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 262543000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Operating Income: 231694000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Operating Revenue: 3352558000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 526971060.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: -104808000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 697022000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 8308000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: -10260415000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 148150000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: 70198000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 356000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -1395000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 2313000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 14438000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Payable: 14064000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Properties: 661596000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 356000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 53876000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Other Special Charges: 3025000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Payables: 1060945000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 25857000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 724599000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Pretax Income: 169037000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 0.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -163803000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 171331000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 2734405000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 195627000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 790000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 790000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 53876000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: -20311196000.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
DIACABS.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 68001000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 176454000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Share Issued: 526971060.00
DIACABS.NS income_statement (annual, 2024-03-31) — Special Income Charges: -3025000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: -9733444000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: -9733444000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: -907500.00
DIACABS.NS income_statement (annual, 2024-03-31) — Tax Provision: -1213000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
DIACABS.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 0.00
DIACABS.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: 0.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Assets: 15181071000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 13189846000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Debt: 23552399000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: -9733444000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Total Expenses: 3120864000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 24914515000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 12567399000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 22952599000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 59000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 13322000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Total Unusual Items: -3025000.00
DIACABS.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: -3025000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Work In Process: 613857000.00
DIACABS.NS balance_sheet (annual, 2024-03-31) — Working Capital: 651753000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 1408295000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 891793000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 0.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 30080000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 340005000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 396838000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: -9229400000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 2080381000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 4085073000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 2147000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 443000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 2590000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 2160798000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 58020000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 12587120000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 1981088000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: -6355342000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 0.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 27933000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 2873615000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 2901548000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 2544000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 2534053000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 12587120000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: -9229400000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 0.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 815354000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 691893000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: -9756371000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 36790000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -1000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 10506739000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 56833000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Payables: 1408295000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 526971060.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: -9229400000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: -9229400000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 16718399000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: -6355785000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 2904138000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: -9229400000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 25947799000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 12633326000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 23787001000.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
DIACABS.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 1924275000.00
DIACABS.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.12
DIACABS.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
DIACABS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 1289508000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 392392000.00
DIACABS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 11153925000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3338083000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1984789000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1984789000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1756088000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1756088000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5464867000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5464867000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -9780465000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Amortization: 3866000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 10744000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 10744000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 530733846.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 510933333.00
DIACABS.NS income_statement (annual, 2025-03-31) — Basic EPS: 0.65
DIACABS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.15
DIACABS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 44486000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1929584000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1929584000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -676736000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 28613000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 28613000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 71765000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 71765000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 71765000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 71765000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 71765000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 71765000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -852460000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -157207000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 722714000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Change In Payable: 951229000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -1168219000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -501791000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 27279000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 526971000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: -8786602000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: -8786602000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1349246000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1349246000.00
DIACABS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 9399411000.00
DIACABS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2862987000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4829235000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4829235000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 2663000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 2663000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1350000000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1350000000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1352663000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1352663000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 4389911000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4389911000.00
DIACABS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 548000.00
DIACABS.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 548000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Depreciation: 202773000.00
DIACABS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 202773000.00